Market size, growth to 2033 and clinical trials, side by side.
China is the bigger Over The Counter (OTC) Consumer market: $12.1 Bn against $2.7 Bn in 2023, about 4.4 times as large.
India grows faster: 8.2% a year, against 6.7%. The gap still grows from $9.4 Bn to $17.2 Bn by 2033.
Clinical research: 17 active trials in China, 1 in India.
| Measure | ||
|---|---|---|
| Market size, 2023 | $12.1 Bn | $2.7 Bn |
| Market size, 2033 projected | $23.2 Bn | $6 Bn |
| Growth a year (CAGR) | 6.7% | 8.2% |
| Money added, 2023–2033 | $11.1 Bn | $3.3 Bn |
| Share of the world market | 8% | 1.8% |
| Size rank of 24 countries | #2 | #12 |
| Market per person, 2023 | $8.63 | $1.88 |
| Active clinical trials | 17 | 1 |
| Full report | China report | India report |
China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
China is the bigger Over The Counter (OTC) Consumer market: $12.1 Bn against $2.7 Bn in 2023, about 4.4 times as large.
India grows faster: 8.2% a year, against 6.7%. The gap still grows from $9.4 Bn to $17.2 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.